ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 352 out of 1456

$524K Total Retail Price of All Prescriptions

Rank: 420 out of 1456

334 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,055 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 506 502 1 4
AMLODIPINE BESYLATE 342 336 2 1
MIRTAZAPINE 334 334 3 65
GABAPENTIN 322 299 4 13
FUROSEMIDE 299 275 5 7
HYDROCODONE-ACETAMINOPHEN 267 235 S3 6 6
WARFARIN SODIUM 245 240 7 21
PRAVASTATIN SODIUM 243 242 8 9
METOPROLOL TARTRATE 235 231 9 12
DONEPEZIL HCL 233 233 10 29
NAMENDA 229 229 11 38
OMEPRAZOLE 225 201 12 5
POTASSIUM CHLORIDE 216 216 13 15
SERTRALINE HCL 213 213 14 25
SIMVASTATIN 207 200 15 2
LISINOPRIL 202 173 16 3
TRAMADOL HCL 176 157 17 17
PANTOPRAZOLE SODIUM 153 153 18 43
FLUTICASONE PROPIONATE 146 137 19 28
METFORMIN HCL 143 139 20 8
HYDROCHLOROTHIAZIDE 122 121 21 10
CLOPIDOGREL 116 116 22 32
ATORVASTATIN CALCIUM 95 84 23 11
CARVEDILOL 86 86 24 20
TAMSULOSIN HCL 85 74 25 34
ATENOLOL 79 79 26 18
QUETIAPINE FUMARATE 75 75 27 78
ZOLPIDEM TARTRATE 75 75 27 14
DIGOXIN 72 72 29 62
ALLOPURINOL 71 71 30 31
CITALOPRAM HBR 70 70 31 22
CARBIDOPA-LEVODOPA 67 67 32 141
TRAZODONE HCL 66 53 33 47
FENTANYL 64 64 S2 34 114
PLAVIX 64 64 34 46
ISOSORBIDE MONONITRATE ER 63 63 36 60
DIOVAN 60 60 37 35
CIPROFLOXACIN HCL 58 54 38 58
METOPROLOL SUCCINATE 56 56 39 19
LOSARTAN POTASSIUM 56 56 39 16
ESCITALOPRAM OXALATE 56 56 39 74
ALENDRONATE SODIUM 55 55 42 36
FAMOTIDINE 55 55 42 45
LOVASTATIN 54 54 44 40
KLOR-CON M20 54 41 44 51
GLIPIZIDE 54 47 44 53
PREDNISONE 51 51 47 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.